Presentation ACC 2018 A Pragmatic Randomized Trial of CYP2C19 Genotyping Implementation Following Percutaneous Coronary Intervention (PCI) Presenter: Sony Tuteja March 12, 2018
Presentation ACC 2018 A Phase II Randomized Double-Blind, Placebo Controlled Study in Patients with Critical Limb Ischemia to Evaluate the Safety and Efficacy of hSDF-1 plasmid (JVS-100) Post Open or Endovascular Revascularization (STOP-PAD Trial) Presenter: Mehdi H. Shishehbor March 12, 2018
Presentation ACC 2018 Comparison of Effectiveness, Safety, and The Net Clinical Outcome Between Different Direct Oral Anticoagulants Presenter: Steve Deitelzweig March 12, 2018
Presentation ACC 2018 ARTEMIS: Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study Presenter: Tracy Wang March 12, 2018
Presentation ACC 2018 MANAGE: Dabigatran in Myocardial Injury After Noncardiac Surgery Presenter: Philip Devereaux March 12, 2018
Presentation ACC 2018 High Rate of Amputation and Death after Major Adverse Limb Events (MALE) in Peripheral Artery Disease: Results from COMPASS Presenter: Sonia S. Anand March 11, 2018
Presentation ACC 2018 One-year Clinical Outcomes of the Bio-engineered COMBO stent: Primary Results from the 3614 All-comer Patients in the COMBO Collaboration Presenter: Antonio Colombo March 11, 2018
Presentation ACC 2018 Results of the SWAP (Switching Antiplatelet Therapy) - 4 Study Presenter: Francesco Franchi March 11, 2018
Presentation ACC 2018 Uptake and Utilization of Drug-Eluting Bioresorbable Vascular Scaffolds: A CathPCI Registry Study Presenter: Ajay J. Kirtane March 11, 2018
Presentation ACC 2018 Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout and Cardiovascular Disease (The CARES Trial) Presenter: William B. White March 11, 2018
Presentation ACC 2018 Hospital Readmission Following Perioperative Myocardial Infarction Associated with Non-Cardiac Surgery Presenter: Nathaniel R. Smilowitz March 11, 2018
Presentation ACC 2018 The ODYSSEY OUTCOMES Trial: Topline Results Alirocumab in Patients After Acute Coronary Syndrome Presenter: Philippe Gabriel Steg March 10, 2018
Presentation ACC 2017 A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS Presenter: Magnus Ohman March 27, 2017
Presentation ACC 2017 Cerebral Embolic Protection In Patients Undergoing Surgical Aortic Valve Replacement (SAVR) Presenter: Michael Mack March 20, 2017
Presentation ACC 2017 iFR vs FFR-guided Coronary Intervention – iFR-SWEDEHEART Presenter: Matthias Götberg March 20, 2017
Presentation ACC 2017 Results of the CARAT Study: Effect of Serial Infusions of CER-001, a Pre-Beta High-Density Lipoprotein Mimetic on Coronary Atherosclerosis Presenter: Stephen J Nicholls March 20, 2017
Presentation ACC 2017 EINSTEIN CHOICE: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism Presenter: Jeff Weitz March 20, 2017
Presentation ACC 2017 DECISION-CTO: Optimal Medical Therapy With or Without Stenting For Coronary Chronic Total Occlusion Presenter: Seung-Jung Park March 20, 2017
Presentation ACC 2017 Randomised Trial of FFR-guided Complete Revascularization versus Infarct Artery only Treatment in Multivessel STEMI Patients Presenter: Pieter Smits March 20, 2017